Literature DB >> 18190860

Molecule-pharmacophore superpositioning and pattern matching in computational drug design.

Gerhard Wolber1, Thomas Seidel, Fabian Bendix, Thierry Langer.   

Abstract

Three-dimensional (3D) pharmacophore modeling is a technique for describing the interaction of a small molecule ligand with a macromolecular target. Since chemical features in a pharmacophore model are well known and highly transparent for medicinal chemists, these models are intuitively understandable and have been increasingly successful in computational drug discovery in the past few years. The performance and applicability of pharmacophore modeling depends on two main factors: the definition and placement of pharmacophoric features and the alignment techniques used to overlay 3D pharmacophore models and small molecules. An overview of key technologies and latest developments in the area of 3D pharmacophores is given and provides insight into different approaches as implemented by the 3D pharmacophore modeling packages like Catalyst, MOE, Phase and LigandScout.

Mesh:

Substances:

Year:  2007        PMID: 18190860     DOI: 10.1016/j.drudis.2007.09.007

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  54 in total

Review 1.  Ingestion-controlling network: what's language got to do with it?

Authors:  Michael Myslobodsky; Richard Coppola
Journal:  Rev Neurosci       Date:  2010       Impact factor: 4.353

2.  Virtual screening and evaluation of Ketol-Acid Reducto-Isomerase (KARI) as a putative drug target for Aspergillosis.

Authors:  Vivek K Morya; Shalini Kumari; Eun-Ki Kim
Journal:  Clin Proteomics       Date:  2012-02-03       Impact factor: 3.988

3.  Avalanche for shape and feature-based virtual screening with 3D alignment.

Authors:  David J Diller; Nancy D Connell; William J Welsh
Journal:  J Comput Aided Mol Des       Date:  2015-10-12       Impact factor: 3.686

4.  Medicinal chemistry for 2020.

Authors:  Seetharama D Satyanarayanajois; Ronald A Hill
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

Review 5.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Development and validation of an improved algorithm for overlaying flexible molecules.

Authors:  Robin Taylor; Jason C Cole; David A Cosgrove; Eleanor J Gardiner; Valerie J Gillet; Oliver Korb
Journal:  J Comput Aided Mol Des       Date:  2012-04-27       Impact factor: 3.686

Review 7.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

8.  Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.

Authors:  Bill R Miller; Adrian E Roitberg
Journal:  J Mol Graph Model       Date:  2013-08-16       Impact factor: 2.518

9.  Ensemble pharmacophore meets ensemble docking: a novel screening strategy for the identification of RIPK1 inhibitors.

Authors:  S M Fayaz; G K Rajanikant
Journal:  J Comput Aided Mol Des       Date:  2014-07-01       Impact factor: 3.686

10.  BCL::MolAlign: Three-Dimensional Small Molecule Alignment for Pharmacophore Mapping.

Authors:  Benjamin P Brown; Jeffrey Mendenhall; Jens Meiler
Journal:  J Chem Inf Model       Date:  2019-02-12       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.